These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1346679)

  • 21. Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group.
    Eur Neurol; 1991; 31(5):300-5. PubMed ID: 1653137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan.
    Pascual J; Quijano J
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):407. PubMed ID: 9728969
    [No Abstract]   [Full Text] [Related]  

  • 23. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 24. Sumatriptan in acute migraine: pharmacology and review of world experience.
    Peroutka SJ
    Headache; 1990; 30 Suppl 2():554-60. PubMed ID: 2177047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acute migraine with subcutaneous GR43175 in West Germany.
    Baar HA; Brand J; Doenicke A; Melchart D; Lüben V; Tryba M; Sahlender HM
    Cephalalgia; 1989; 9 Suppl 9():83-7. PubMed ID: 2544289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine.
    Cady RK; Dexter J; Sargent JD; Markley H; Osterhaus JT; Webster CJ
    Neurology; 1993 Jul; 43(7):1363-8. PubMed ID: 8392150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early clinical experience with subcutaneous GR43175 in acute migraine: an overview.
    Tfelt-Hansen P; Brand J; Dano P; Doenicke A; Findley LJ; Iversen HK; Melchart D; Sahlender HM
    Cephalalgia; 1989; 9 Suppl 9():73-7. PubMed ID: 2544287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sumatriptan and recurrence of migraine.
    Blau JN
    Lancet; 1992 Oct; 340(8827):1110. PubMed ID: 1357514
    [No Abstract]   [Full Text] [Related]  

  • 29. Sumatriptan: efficacy and contribution to migraine mechanisms.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
    [No Abstract]   [Full Text] [Related]  

  • 30. Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being.
    Dahlöf C; Edwards C; Toth A
    Cephalalgia; 1992 Aug; 12(4):214-20. PubMed ID: 1326404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sumatriptan (Imigran) to patients with hemiplegic migraine?].
    Thomsen LL; Iversen HK; Olesen J
    Ugeskr Laeger; 1992 Aug; 154(33):2271. PubMed ID: 1329297
    [No Abstract]   [Full Text] [Related]  

  • 32. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial clinical experience with the use of subcutaneous GR43175 in treating acute migraine.
    Brion N; Bons J; Plas J; Bayliss EM; Advenier C
    Cephalalgia; 1989; 9 Suppl 9():79-82. PubMed ID: 2544288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sumatriptan and recurrence of migraine.
    Lloyd DK; Pilgrim AJ
    Lancet; 1992 Oct; 340(8827):1110. PubMed ID: 1357515
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice.
    Scott RJ; Aitchison WR; Barker PR; McLaren GI
    QJM; 1996 Aug; 89(8):613-22. PubMed ID: 8935482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of triptanes according to indications. Risk of infarct is not increased].
    MMW Fortschr Med; 2004 Feb; 146(7):60. PubMed ID: 15347059
    [No Abstract]   [Full Text] [Related]  

  • 37. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sumatriptan in migraine and cluster headache].
    Ferrari MD
    Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1573-5. PubMed ID: 1656279
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sumatriptan--future development, alternative features and potential new indications].
    Arnold WS
    Neurol Neurochir Pol; 1992; Suppl 2():49-56. PubMed ID: 1337767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.